Cargando…
Translating translational medicine into global health equity: What is needed?
While genomics, and other omics, research is rapidly advancing in the US and Europe, progress has been slower in less resourced countries. The imbalance has given rise to concern about whether the benefits of these advances, namely new and better tests, treatments, risk identification, and preventio...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4911426/ https://www.ncbi.nlm.nih.gov/pubmed/27354940 http://dx.doi.org/10.1016/j.atg.2016.03.004 |
_version_ | 1782438127344812032 |
---|---|
author | Isaacson Barash, Carol |
author_facet | Isaacson Barash, Carol |
author_sort | Isaacson Barash, Carol |
collection | PubMed |
description | While genomics, and other omics, research is rapidly advancing in the US and Europe, progress has been slower in less resourced countries. The imbalance has given rise to concern about whether the benefits of these advances, namely new and better tests, treatments, risk identification, and prevention strategies, will be shared and available to those living in less resourced reaches of the globe. In effort to give voice to researchers, an informal survey about barriers to advancing translational medicine was administered to attendees of the 11th Asia Pacific Conference on Human Genetics, 2015, Hanoi. The overall goal of the survey was to identify unmet needs and rank their importance. Most attendees completed the survey. Not surprisingly funding is indicated as a major need. Respondents reported that lack of bioinformatics and computational tools, trained data scientists and access to datasets is creating a significant lag behind better resourced regions. Results are intended to inform efforts to create a regional consensus statement of need. Such a regional statement could help funding organizations and policy makers seeking to promote global genomics benefit sharing. |
format | Online Article Text |
id | pubmed-4911426 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-49114262016-06-28 Translating translational medicine into global health equity: What is needed? Isaacson Barash, Carol Appl Transl Genom Article While genomics, and other omics, research is rapidly advancing in the US and Europe, progress has been slower in less resourced countries. The imbalance has given rise to concern about whether the benefits of these advances, namely new and better tests, treatments, risk identification, and prevention strategies, will be shared and available to those living in less resourced reaches of the globe. In effort to give voice to researchers, an informal survey about barriers to advancing translational medicine was administered to attendees of the 11th Asia Pacific Conference on Human Genetics, 2015, Hanoi. The overall goal of the survey was to identify unmet needs and rank their importance. Most attendees completed the survey. Not surprisingly funding is indicated as a major need. Respondents reported that lack of bioinformatics and computational tools, trained data scientists and access to datasets is creating a significant lag behind better resourced regions. Results are intended to inform efforts to create a regional consensus statement of need. Such a regional statement could help funding organizations and policy makers seeking to promote global genomics benefit sharing. Elsevier 2016-03-10 /pmc/articles/PMC4911426/ /pubmed/27354940 http://dx.doi.org/10.1016/j.atg.2016.03.004 Text en © 2016 The Author http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Article Isaacson Barash, Carol Translating translational medicine into global health equity: What is needed? |
title | Translating translational medicine into global health equity: What is needed? |
title_full | Translating translational medicine into global health equity: What is needed? |
title_fullStr | Translating translational medicine into global health equity: What is needed? |
title_full_unstemmed | Translating translational medicine into global health equity: What is needed? |
title_short | Translating translational medicine into global health equity: What is needed? |
title_sort | translating translational medicine into global health equity: what is needed? |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4911426/ https://www.ncbi.nlm.nih.gov/pubmed/27354940 http://dx.doi.org/10.1016/j.atg.2016.03.004 |
work_keys_str_mv | AT isaacsonbarashcarol translatingtranslationalmedicineintoglobalhealthequitywhatisneeded |